Contemporary Research Analysis Journal

Malaria and HIV infection are two of the major public health issues in sub-Saharan Africa. High rates of morbidity and mortality are associated with both. In Awo-Omamma, Imo state, the study compared the levels of certain inflammatory mediators and immunoglobulins in HIV patients with co-infection with malaria and those who did not have malaria. 102 (34%) of the 300 volunteers that were enlisted for the study were men, and 198 (66%) were women.Of the patients in this study, one hundred (33.3%) had co-infections with malaria and HIV. The study's findings demonstrated a substantial variation in CD4 counts between the groups under investigation. (P=0.001, F=22.5). When compared to the average of HIV mono-infected individuals (488±100.5 cells/mm3) and control participants (909±102 cells/mm3), the mean CD4+ of HIV-malaria co-infected subjects (384.7±101.5 cells/mm3) was significantly lower. correspondingly (P=0.0001, P=0.0001). When compared to the means of HIV mono-infected individuals (37.6±9.8 mg/dl) and control subjects (5.6±2.9 mg/dl), respectively, the mean ± SD value of C-reactive protein (CRP) in HIV-malaria co-infected participants (56±21.3 mg/dl) was substantially greater (P=0.0001, P=0.0001). HIV-malaria co-infected individuals had a statistically higher mean value of C3 (203.6±105 mg/dl) than HIV mono-infected individuals (152.3±90.5 mg/dl) and the control group (104.7±56.9 mg/dl), respectively (P=0.05, 0.04). In a similar vein, the mean IL-6 of individuals co-infected with HIV and malaria (54.4±19.6 mg/dl) was considerably greater than the averages of individuals infected with HIV alone (38.3±14.9 mg/dl) and control subjects (5.8±1.8 mg/dl) (P=0.0001, P˂0.001). Additionally, it was noted that whereas CRP and IL-6 were higher in HIV mono-infected individuals than in control participants, there was no discernible difference between the two groups' C3 and C4. In summary, adult HIV/malaria co-infection heightens humoral and inflammatory responses, particularly for C-reactive protein (CRP), complement 3 (C3), and interleukin-6 (IL-6). Furthermore, ART demonstrated a drop in IL-6 and CRP levels.

C-Reactive Protein, Complement 3, Complement 4, Interleukin 6 , Hiv-Malaria Co-Infected, Awo-Omamma

1. Adeola, O. O., Kolawole, O. E., Yemi, A. F., Hilda, A. E., Samson, A. T., & Kola, O. J. (2022). Occurrence and clinical features of HIV and malaria in co-infected individuals in Osun State, Nigeria. Journal of Family Medicine and Primary Care, 11(9), 5332–5332. 
2. Sonawane, R. B., & Barkade, G. D. (2023). Literature Review on Acquired Immunodeficiency Syndrome (AIDS). Systematic Reviews in Pharmacy, 14(5).
3. Anywaine, Z., Levin, J., Kasirye, R., Lutaakome, J. K., Abaasa, A., Nunn, A., Grosskurth, H., & Munderi, P. (2018). Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial. PLOS ONE, 13(12), e0206907. 
4. Bhusal, R. P., Foster, S. R., & Stone, M. J. (2019). Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responses. Protein Science, 29(2), 420–432. 
5. Gomo R, & Sibanda, E. N. (2003). Determination of normal ranges for serum C3 and C4 levels in an adult Zimbabwean population. PubMed, 48(11-12), 137–141.
6. Stacey, A. R., Norris, P. J., Qin, L., Haygreen, E. A., Taylor, E., Heitman, J., ... & Borrow, P. (2009). Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. Journal of virology, 83(8), 3719-3733. 
7. Wang, Z., Shang, H., & Jiang, Y. (2017). Chemokines and chemokine receptors: accomplices for human immunodeficiency virus infection and latency. Frontiers in Immunology, 8. 
8. Ansar, W., Bandyopadhyay, S. M. nee, Chowdhury, S., Habib, SK. H., & Mandal, C. (2006). Role of C-reactive protein in complement-mediated hemolysis in Malaria. Glycoconjugate Journal, 23(3-4), 233–240. 
9. He, J., Wei, Y., Li, J., Tang, Y., Liu, J., He, Z., Zhou, R., He, X., Ren, H., Liao, Y., Gu, L., Yuan, N., Chen, X., & Tang, J. (2023). Sex differences in the association of treatment-resistant schizophrenia and serum interleukin-6 levels. BMC Psychiatry, 23(1). 
10. Hensley-McBain, T., & Klatt, N. R. (2018). The dual role of neutrophils in HIV infection. Current HIV/AIDS Reports, 15(1), 1–10. 
11. Wilairatana, P., Mala, W., Milanez, G. D. J., Masangkay, F. R., Kotepui, K. U., & Kotepui, M. (2022). Increased interleukin-6 levels associated with malaria infection and disease severity: a systematic review and meta-analysis. Scientific Reports, 12, 5982. 
12. Briggs, J. A., & Kräusslich, H. (2011). The molecular architecture of HIV. Journal of Molecular Biology/Journal of Molecular Biology, 410(4), 491–500. 
13. Colomer-Lluch, M., Castro-Gonzalez, S., & Serra-Moreno, R. (2020). Ubiquitination and SUMOylation in HIV infection: friends and foes. Current Issues in Molecular Biology, 159–194. 
14. Zhuang, S., & Torbett, B. E. (2021). Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel Therapeutics. Viruses, 13(3), 417. 
15. Hu, G., Wang, T., Liu, J., Chen, Z., Zhong, L., Yu, S., Zhao, Z., Zhai, M., & Jia, G. (2017). Serum protein expression profiling and bioinformatics analysis in workers occupationally exposed to chromium (VI). Toxicology Letters, 277, 76–83. 
16. Ireri, J. M. (2022). C-Reactive Protein Levels in Male and Female Blood Donors at Kenyatta National Hospital, Kenya. Advances in Social Sciences Research Journal, 9(2), 222–227. 
17. Chen, B. (2019). Molecular mechanism of HIV-1 entry. Trends in Microbiology, 27(10), 878–891. 
18. Kwenti, T. E. (2018). Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies. Research and Reports in Tropical Medicine, Volume 9, 123–136. 
19. Cohn, L. B., Chomont, N., & Deeks, S. G. (2020). The biology of the HIV-1 latent reservoir and implications for cure strategies. Cell Host & Microbe, 27(4), 519–530. https://doi.org/10.1016/j.chom.2020.03.014
20. Jegede, F. E., Oyeyi, T. I., Abdulrahman, S. A., Mbah, H. Akwen., Badru, T., Agbakwuru, C., & Adedokun, O. (2017). Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria. PLOS ONE, 12(3), e0174233. 
21. Lau, B. (2006). C-Reactive Protein Is a Marker for Human Immunodeficiency Virus Disease Progression. Archives of Internal Medicine, 166(1), 64. 
22. Mirzohreh, S.-T., Safarpour, H., Pagheh, A. S., Bangoura, B., Barac, A., & Ahmadpour, E. (2022). Malaria prevalence in HIV-positive children, pregnant women, and adults: a systematic review and meta-analysis. Parasites & Vectors, 15(1).
23. Nakanjako, D., Ssewanyana, I., Mayanja-Kizza, H., Kiragga, A., Colebunders, R., Manabe, Y. C., ... & Cao, H. (2011). High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. BMC infectious diseases, 11(1), 1-9. 
24. Kleinpeter, A. B., & Freed, E. O. (2020). HIV-1 Maturation: Lessons Learned from Inhibitors. Viruses, 12(9), 940. 
25. Shafi´u Dahiru G, Abdulrasul I, Adebola T.O, Muhammed S.I, Muhammad S.B, Afara D, Ikeoluwapo A, Olufemi A, Isiyaku A, Abubakar S, Asma’u I.M and Habibu A (2021). HIV-Malaria co-infection and its determinants among patients attending antiretroviral treatment clinic in Zaria, Kaduna State, Nigeria. Journal of Interventional Epidemiology and Public Health 4:2.